Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer.

Takamori, Shinkichi; Shimokawa, Mototsugu; Komiya, Takefumi

Takamori, Shinkichi; Shimokawa, Mototsugu; Komiya, Takefumi.

Afiliação

Takamori S; Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, 879-5593, Japan.
Shimokawa M; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-0054, Japan.
Komiya T; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.

J Cancer Res Clin Oncol ; 149(14): 13175-13184, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37477693

Palavras-chave

Age; Immune checkpoint inhibitor; Non-small cell lung cancer; Programmed cell death-1; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google